Evidence map›Paper›PMID 29430580›Full record

ReviewHeart failure reviews2018

Devices and interventions for the prevention of adverse outcomes of tachycardia on heart failure.

Jasneet Devgun, Yash B Jobanputra, Michael Arustamyan, Robert Chait, Waqas Ghumman

Abstract readReview
PubMed Publisher
In one paragraph

Review in Heart failure reviews, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jasneet DevgunDepartment of Internal Medicine, The Ohio State University Wexner Medical Center, 395 W 12th Avenue Third Floor, Columbus, OH, 43210, USA. Jasneet.devgun@osumc.edu.
Yash B JobanputraDepartment of Internal Medicine, University of Miami Miller School of Medicine Regional Campus, Atlantis, FL, USA.
Michael ArustamyanLake Erie College of Osteopathic Medicine, Erie, PA, USA.
Robert ChaitDepartment of Cardiology, University of Miami Miller School of Medicine Regional Campus, Atlantis, FL, USA.
Waqas GhummanDepartment of Cardiology, University of Miami Miller School of Medicine Regional Campus, Atlantis, FL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart failure (HF) is the leading cause of hospitalization in the USA. Despite advances in pharmacologic management, the incidence of HF is on the rise and survivability is persistently reduced. Sympathetic overdrive is implicated in the pathophysiology of HF, particularly HF with reduced ejection fraction (HFrEF). Tachycardia can be particularly deleterious and thus has spurred significant investigation to mitigate its effects. Various modalities including vagus nerve stimulation, baroreceptor activation therapy, spinal cord stimulation, renal sympathetic nerve denervation, left cardiac sympathetic denervation, and carotid body removal will be discussed. However, the effects of these modalities on tachycardia and its outcomes in HFrEF have not been well-studied. Further studies to characterize this are necessary in the future.

Indexed as

Heart FailureHumansSpinal Cord StimulationStroke VolumeSympathectomyTachycardiaVagus Nerve StimulationVentricular Function, LeftBaroreceptor activation therapyHeart failureRenal sympathetic nerve denervationTachycardiaVagus nerve stimulation

Identifiers

PMID29430580

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.